BioCentury
ARTICLE | Financial News

S1 Biopharma files for IPO

October 2, 2014 2:57 AM UTC

S1 Biopharma Inc. (New York, N.Y.) proposed to raise up to $40.3 million in an IPO on NASDAQ underwritten by MLV. The biotech's lead product is lorexys, an oral fixed-dose enteric formulation of bupro...